Specific c-Jun target genes in malignant melanoma

References

• Shaulian E. AP-1–The Jun proteins: Oncogenes or tumor suppressors in disguise? Cellular signalling 2010; 22(6):894-9; PMID:20060892; http://dx.doi.org/10.1016/j.cellsig.2009.12.008
   PubMed Web of Science ®Google Scholar
• Vogt PK. Jun, the oncoprotein. Oncogene 2001; 20(19):2365-77; PMID:11402333; http://dx.doi.org/10.1038/sj.onc.1204443
   PubMed Web of Science ®Google Scholar
• Chinenov Y, Kerppola TK. Close encounters of many kinds: Fos-Jun interactions that mediate transcription regulatory specificity. Oncogene 2001; 20(19):2438-52; PMID:11402339; http://dx.doi.org/10.1038/sj.onc.1204385
   PubMed Web of Science ®Google Scholar
• Shaulian E, Karin M. AP-1 in cell proliferation and survival. Oncogene 2001; 20(19):2390-400; PMID:11402335; http://dx.doi.org/10.1038/sj.onc.1204383
   PubMed Web of Science ®Google Scholar
• Kappelmann M, Bosserhoff A, Kuphal S. AP-1/c-Jun transcription factors: Regulation and function in malignant melanoma. Eur J Cell Biol 2014; 93(1-2): p. 76-81. -81 PMID:24315690
   PubMed Web of Science ®Google Scholar
• Eferl R, Wagner EF. AP-1: a double-edged sword in tumorigenesis. Nature reviews Cancer 2003; 3(11):859-68; PMID:14668816; http://dx.doi.org/10.1038/nrc1209
   PubMed Web of Science ®Google Scholar
• Mundade R, Ozer HG, Wei H, Prabhu L, Lu T. Role of ChIP-seq in the discovery of transcription factor binding sites, differential gene regulation mechanism, epigenetic marks and beyond. Cell cycle (Georgetown, Tex) 2014; 13(18):2847-52; PMID:25486472; http://dx.doi.org/10.4161/15384101.2014.949201
   PubMed Web of Science ®Google Scholar
• Lee TI, Johnstone SE, Young RA. Chromatin immunoprecipitation and microarray-based analysis of protein location. Nature protocols 2006; 1(2):729-48; PMID:17406303; http://dx.doi.org/10.1038/nprot.2006.98
   PubMed Web of Science ®Google Scholar
• Jochum W, Passegue E, Wagner EF. AP-1 in mouse development and tumorigenesis. Oncogene 2001; 20(19):2401-12; PMID:11402336; http://dx.doi.org/10.1038/sj.onc.1204389
   PubMed Web of Science ®Google Scholar
• Weiss C, Bohmann D. Deregulated repression of c-Jun provides a potential link to its role in tumorigenesis. Cell cycle (Georgetown, Tex) 2004; 3(2):111-3; PMID:14712066; http://dx.doi.org/10.4161/cc.3.2.648; 20 and 23
   PubMed Web of Science ®Google Scholar
• Kappelmann M, Kuphal S, Meister G, Vardimon L, Bosserhoff AK. MicroRNA miR-125b controls melanoma progression by direct regulation of c-Jun protein expression. Oncogene 2013; 32(24):2984-91; PMID:22797068; http://dx.doi.org/10.1038/onc.2012.307
   PubMed Web of Science ®Google Scholar
• Spangler B, Kappelmann M, Schittek B, Meierjohann S, Vardimon L, Bosserhoff AK, Kuphal S. ETS-1/RhoC signaling regulates the transcription factor c-Jun in melanoma. Int J Cancer Journal international du cancer 2012; 130(12):2801-11; PMID:21732343; http://dx.doi.org/10.1002/ijc.26277
   PubMed Web of Science ®Google Scholar
• Spangler B, Vardimon L, Bosserhoff AK, Kuphal S. Post-transcriptional regulation controlled by E-cadherin is important for c-Jun activity in melanoma. Pigment Cell Melanoma Res 2011; 24(1):148-64; PMID:20977688; http://dx.doi.org/10.1111/j.1755-148X.2010.00787.x
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, Forslund K, Heller D, Huerta-Cepas J, Simonovic M, Roth A, Santos A, Tsafou KP, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res 2015; 43(Database issue):D447-52; PMID:25352553; http://dx.doi.org/10.1093/nar/gku1003
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, Collins JR, Alvord WG, Roayaei J, Stephens R, Baseler MW, Lane HC, Lempicki RA. The DAVID Gene Functional Classification Tool: a novel biological module-centric algorithm to functionally analyze large gene lists. Genome Biol 2007; 8(9):R183; PMID:17784955; http://dx.doi.org/10.1186/gb-2007-8-9-r183
   PubMed Web of Science ®Google Scholar
• Huang DW, Sherman BT, Tan Q, Kir J, Liu D, Bryant D, Guo Y, Stephens R, Baseler MW, Lane HC, et al. DAVID Bioinformatics Resources: expanded annotation database and novel algorithms to better extract biology from large gene lists. Nucleic Acids Res 2007; 35(Web Server issue):W169-75; PMID:17576678; http://dx.doi.org/10.1093/nar/gkm415
   PubMed Web of Science ®Google Scholar
• Yang S, McNulty S, Meyskens FL, Jr. During human melanoma progression AP-1 binding pairs are altered with loss of c-Jun in vitro. Pigment Cell Res 2004; 17(1):74-83; PMID:14717848; http://dx.doi.org/10.1046/j.1600-0749.2003.00114.x
   PubMedGoogle Scholar
• Perotti V, Baldassari P, Bersani I, Molla A, Vegetti C, Tassi E, Dal Col J, Dolcetti R, Anichini A, Mortarini R. NFATc2 is a potential therapeutic target in human melanoma. J Investigative Dermatol 2012; 132(11):2652-60; PMID:22718120; http://dx.doi.org/10.1038/jid.2012.179
   PubMed Web of Science ®Google Scholar
• Bhattacharya A, Schmitz U, Wolkenhauer O, Schönherr M, Raatz Y, Kunz M. Regulation of cell cycle checkpoint kinase WEE1 by miR-195 in malignant melanoma. Oncogene 2013; 32(26):3175-83; PMID:22847610; http://dx.doi.org/10.1038/onc.2012.324
   PubMed Web of Science ®Google Scholar
• Sloan KE, Eustace BK, Stewart JK, Zehetmeier C, Torella C, Simeone M, Roy JE, Unger C, Louis DN, Ilag LL, et al. CD155/PVR plays a key role in cell motility during tumor cell invasion and migration. BMC Cancer 2004; 4:73; PMID:15471548
   PubMed Web of Science ®Google Scholar
• Liu H, He Z, Simon HU. Autophagy suppresses melanoma tumorigenesis by inducing senescence. Autophagy 2014; 10(2):372-3; PMID:24300435; http://dx.doi.org/10.4161/auto.27163
   PubMed Web of Science ®Google Scholar
• Schoof N, Iles MM, Bishop DT, Newton-Bishop JA, Barrett JH, Genomel Consortium. Pathway-based analysis of a melanoma genome-wide association study: analysis of genes related to tumour-immunosuppression. PloS One 2011; 6(12):e29451; PMID:22216283; http://dx.doi.org/10.1371/journal.pone.0029451
   PubMedGoogle Scholar
• Bailey TL, Elkan C. Fitting a mixture model by expectation maximization to discover motifs in biopolymers. Proc Int Conf Intell Syst Mol Biol 1994; 2:28-36; PMID:7584402
   PubMedGoogle Scholar
• Poser I, Tatzel J, Kuphal S, Bosserhoff AK. Functional role of MIA in melanocytes and early development of melanoma. Oncogene 2004; 23(36):6115-24; PMID:15208686; http://dx.doi.org/10.1038/sj.onc.1207797
   PubMed Web of Science ®Google Scholar
• Bakiri L, Lallemand D, Bossy-Wetzel E, Yaniv M. Cell cycle-dependent variations in c-Jun and JunB phosphorylation: a role in the control of cyclin D1 expression. EMBO JJ 2000; 19(9):2056-68; PMID:10790372; http://dx.doi.org/10.1093/emboj/19.9.2056
   PubMed Web of Science ®Google Scholar
• Schreiber M, Kolbus A, Piu F, Szabowski A, Möhle-Steinlein U, Tian J, Karin M, Angel P, Wagner EF. Control of cell cycle progression by c-Jun is p53 dependent. Genes Dev 1999; 13(5):607-19; PMID:10072388; http://dx.doi.org/10.1101/gad.13.5.607
   PubMed Web of Science ®Google Scholar
• Passegue E, Wagner EF. JunB suppresses cell proliferation by transcriptional activation of p16(INK4a) expression. EMBO J 2000; 19(12):2969-79; PMID:10856241; http://dx.doi.org/10.1093/emboj/19.12.2969
   PubMed Web of Science ®Google Scholar
• Yang-Yen HF, Chambard JC, Sun YL, Smeal T, Schmidt TJ, Drouin J, Karin M. Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction. Cell 1990; 62(6):1205-15; PMID:2169352; http://dx.doi.org/10.1016/0092-8674(90)90396-V
   PubMed Web of Science ®Google Scholar
• Uhlen M, Fagerberg L, Hallstrom BM, Lindskog C, Oksvold P, Mardinoglu A, Sivertsson Å, Kampf C, Sjöstedt E, Asplund A, Proteomics. Tissue-based map of the human proteome. Science (New York, NY) 2015;347(6220):1260419; PMID:25613900; http://dx.doi.org/10.1126/science.1260419
   PubMedGoogle Scholar
• Kim JH, Lee JY, Lee KT, Lee JK, Lee KH, Jang KT, Heo JS, Choi SH, Rhee JC. RGS16 and FosB underexpressed in pancreatic cancer with lymph node metastasis promote tumor progression. Tumour Biol 2010; 31(5):541-8; PMID:20571966; http://dx.doi.org/10.1007/s13277-010-0067-z
   PubMed Web of Science ®Google Scholar
• Bamberger AM, Methner C, Lisboa BW, Städtler C, Schulte HM, Löning T, Milde-Langosch K. Expression pattern of the AP-1 family in breast cancer: association of fosB expression with a well-differentiated, receptor-positive tumor phenotype. Int J Cancer Journal international du cancer 1999; 84(5):533-8; PMID:10502734; http://dx.doi.org/10.1002/(SICI)1097-0215(19991022)84:5%3c533::AID-IJC16%3e3.0.CO;2-J
   PubMed Web of Science ®Google Scholar
• Braeuer RR, Zigler M, Kamiya T, Dobroff AS, Huang L, Choi W, McConkey DJ, Shoshan E, Mobley AK, Song R, et al. Galectin-3 contributes to melanoma growth and metastasis via regulation of NFAT1 and autotaxin. Cancer Res 2012; 72(22):5757-66; PMID:22986745; http://dx.doi.org/10.1158/0008-5472.CAN-12-2424
   PubMed Web of Science ®Google Scholar
• Ghiasi N, Habibagahi M, Rosli R, Ghaderi A, Yusoff K, Hosseini A, Abdullah S, Jaberipour M. Tumour suppressive effects of WEE1 gene silencing in breast cancer cells. Asian Pac J Cancer Prev 2014; 14(11):6605-11; PMID:24377575; http://dx.doi.org/10.7314/APJCP.2013.14.11.6605
   PubMedGoogle Scholar
• Slipicevic A, Holth A, Hellesylt E, Tropé CG, Davidson B, Flørenes VA. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions. Gynecol Oncol 2014; 135(1):118-24; PMID:25093290; http://dx.doi.org/10.1016/j.ygyno.2014.07.102
   PubMed Web of Science ®Google Scholar
• Harris PS, Venkataraman S, Alimova I, Birks DK, Balakrishnan I, Cristiano B, Donson AM, Dubuc AM, Taylor MD, Foreman NK, et al. Integrated genomic analysis identifies the mitotic checkpoint kinase WEE1 as a novel therapeutic target in medulloblastoma. Mol Cancer 2014; 13:72; PMID:24661910; http://dx.doi.org/10.1186/1476-4598-13-72.
   PubMed Web of Science ®Google Scholar
• Haarberg HE, Paraiso KH, Wood E, Rebecca VW, Sondak VK, Koomen JM, Smalley KS. Inhibition of Wee1, AKT, and CDK4 underlies the efficacy of the HSP90 inhibitor XL888 in an in vivo model of NRAS-mutant melanoma. Mol Cancer Ther 2013; 12(6):901-12; PMID:23538902; http://dx.doi.org/10.1158/1535-7163.MCT-12-1003
   PubMed Web of Science ®Google Scholar
• Tane S, Maniwa Y, Hokka D, Tauchi S, Nishio W, Okita Y, Yoshimura M. The role of Necl-5 in the invasive activity of lung adenocarcinoma. Exp Mol Pathol 2013; 94(2):330-5; PMID:23276719; http://dx.doi.org/10.1016/j.yexmp.2012.12.003
   PubMed Web of Science ®Google Scholar
• Bevelacqua V, Bevelacqua Y, Candido S, Skarmoutsou E, Amoroso A, Guarneri C, Strazzanti A, Gangemi P, Mazzarino MC, D'Amico F, et al. Nectin like-5 overexpression correlates with the malignant phenotype in cutaneous melanoma. Oncotarget 2012; 3(8):882-92; PMID:22929570; http://dx.doi.org/10.18632/oncotarget.594
   PubMed Web of Science ®Google Scholar
• Wu DH, Jia CC, Chen J, Lin ZX, Ruan DY, Li X, Lin Q, Min-Dong, Ma XK, Wan XB, et al. Autophagic LC3B overexpression correlates with malignant progression and predicts a poor prognosis in hepatocellular carcinoma. Tumour Biol 2014; 35(12):12225-33; PMID:25256671; http://dx.doi.org/10.1007/s13277-014-2531-7
   PubMed Web of Science ®Google Scholar
• Wang J, Pan XL, Ding LJ, Liu DY, Da-Peng Lei, Jin T. Aberrant expression of Beclin-1 and LC3 correlates with poor prognosis of human hypopharyngeal squamous cell carcinoma. PloS One 2013; 8(7):e69038; PMID:23935917; http://dx.doi.org/10.1371/journal.pone.0069038
   PubMed Web of Science ®Google Scholar
• Olbryt M, Habryka A, Tyszkiewicz T, Rusin A, Cichoń T, Jarząb M, Krawczyk Z. Melanoma-associated genes, MXI1, FN1, and NME1, are hypoxia responsive in murine and human melanoma cells. Melanoma Res 2011; 21(5):417-25; PMID:21912348; http://dx.doi.org/10.1097/CMR.0b013e328348db2f
   PubMed Web of Science ®Google Scholar
• Mourad-Zeidan AA, Melnikova VO, Wang H, Raz A, Bar-Eli M. Expression profiling of Galectin-3-depleted melanoma cells reveals its major role in melanoma cell plasticity and vasculogenic mimicry. Am J Pathol 2008; 173(6):1839-52; PMID:18988806; http://dx.doi.org/10.2353/ajpath.2008.080380
   PubMed Web of Science ®Google Scholar
• Braig S, Bosserhoff AK. Death inducer-obliterator 1 (Dido1) is a BMP target gene and promotes BMP-induced melanoma progression. Oncogene 2013; 32(7):837-48; PMID:22469980; http://dx.doi.org/10.1038/onc.2012.115
   PubMed Web of Science ®Google Scholar
• Wenke AK, Niebler S, Grassel S, Bosserhoff AK. The transcription factor AP-2varepsilon regulates CXCL1 during cartilage development and in osteoarthritis. Osteoarthritis Cartilage 2011; 19(2):206-12; PMID:21134476; http://dx.doi.org/10.1016/j.joca.2010.11.011
   PubMed Web of Science ®Google Scholar
• Kappelmann M, Bosserhoff A, Kuphal S. AP-1/c-Jun transcription factors: regulation and function in malignant melanoma. Eur J Cell Biol 2014; 93(1-2):76-81; PMID:24315690; http://dx.doi.org/10.1016/j.ejcb.2013.10.003
   PubMed Web of Science ®Google Scholar